Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate
Background/AimsThe protease inhibitors, nafamostat and gabexate, have been used to prevent pancreatitis related to endoscopic retrograde cholangiopancreatography (ERCP). In vitro, nafamostat inhibits the pancreatic protease activities 10-100 times more potently than gabexate. We evaluated the effica...
Gespeichert in:
| Format: | Artigo |
|---|---|
| Sprache: | Inglês |
| Veröffentlicht: |
Gastroenterology Council for Gut and Liver
2009-09-01
|
| Schriftenreihe: | Gut and Liver |
| Schlagworte: | |
| Online-Zugang: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl.2009.3.3.205 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|